Literature DB >> 9358471

Leukoplakia: molecular understanding of pre-malignant lesions and implications for clinical management.

L Mao1.   

Abstract

Oral leukoplakia is a white patch or plaque of the oral mucosa that cannot be characterized clinically or pathologically as any other diagnosable disease. Although oral leukoplakia is a well-known oral premalignant lesion with a high risk for development of oral cancer, little is known about its genetic basis. The development of oral cancer is a multistep process and it is believed that multiple genetic alterations are involved. Understanding this underlying genetic basis of oral cancer development will help us design better diagnosis and treatment plans in the cancer clinic. This review discusses recent progress in the identification of genetic and cytogenetic alterations in oral pre-malignant lesions and their potential clinical applications.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358471     DOI: 10.1016/S1357-4310(97)01111-8

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  3 in total

1.  Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization.

Authors:  R G Weber; M Scheer; I A Born; S Joos; J M Cobbers; C Hofele; G Reifenberger; J E Zöller; P Lichter
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

2.  In situ immunohistochemical detection of intracellular Mycoplasma salivarium in the epithelial cells of oral leukoplakia.

Authors:  Harumi Mizuki; Takafumi Kawamura; Dai Nagasawa
Journal:  J Oral Pathol Med       Date:  2014-07-28       Impact factor: 4.253

3.  Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment.

Authors:  Kazumasa Mori; Shigeki Haraguchi; Miki Hiori; Jun Shimada; Yoshihiro Ohmori
Journal:  BMC Cancer       Date:  2015-08-05       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.